Watch the transformation of women who curb their diets, ZP's daughter

The Ozempic, a medication designed to treat type 2 diabetes, has become popularized as a tool for weight loss, but its use without medical supervision raises questions about its long-term safety and efficacy.

## The rise of Ozempic for weight loss

The **Ozempic**, an injectable drug developed by **Novo Nordisk**, has transitioned from a treatment for type 2 diabetes to a media and social phenomenon due to its apparent ability to facilitate weight loss. Its active ingredient, **semaglutide**, mimics a natural hormone called GLP-1, which helps regulate blood sugar levels and, secondarily, reduces appetite and food intake. This dual action has captured the attention of those seeking quick solutions for overweight issues, generating a demand that has exceeded initial manufacturer expectations.

## Medical and economic implications

The prescription of Ozempic is approved for patients with type 2 diabetes, but its 'off-label' use—that is, use for purposes other than those indicated in its technical sheet—has skyrocketed. This presents a complex scenario from both medical and economic viewpoints. On one hand, lack of professional supervision can lead to unwanted side effects, ranging from digestive issues to more serious risks. On the other hand, high demand has caused shortages of the medication, affecting diabetic patients who genuinely need it.

## Risks and precautions

The use of Ozempic without proper indication or medical trinc-up is not without risks. Although semaglutide has proven effective in clinical trials for controlling diabetes and losing weight in certain patient profiles, its administration must always be guided by a healthcare professional. This specialist can evaluate the suitability of the treatment, adjust the dosage, and monitor possible adverse effects. Self-medication or use for purely aesthetic reasons without a prior medical evaluation can lead to health complications.